NCT06030817View on ClinicalTrials.gov

99mTc-CNDG Injection in the Diagnosis of Malignant Tumors

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Malignant Tumor
Interventions
DIAGNOSTIC_TEST

99mTc-CNDG SPECT/CT

Explore the imaging characteristics of 99mTc-CNDG and its diagnostic efficacy in tumor patients.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER